The efficacy of xamoterol in heart failure of ischemic origin.
Marlow
H F
HF
Medical Research Department, ICI Pharmaceuticals, Cheshire, England.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D011412:Propanolamines / Q000627:therapeutic use*; D017307:Xamoterol
D000318:Adrenergic beta-Agonists; D011412:Propanolamines; D017307:Xamoterol